ID   FER_HUMAN               Reviewed;         822 AA.
AC   P16591; B2RCR4; B4DSQ2; H2FLB8;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   10-MAY-2017, entry version 187.
DE   RecName: Full=Tyrosine-protein kinase Fer;
DE            EC=2.7.10.2;
DE   AltName: Full=Feline encephalitis virus-related kinase FER;
DE   AltName: Full=Fujinami poultry sarcoma/Feline sarcoma-related protein Fer;
DE   AltName: Full=Proto-oncogene c-Fer;
DE   AltName: Full=Tyrosine kinase 3;
DE   AltName: Full=p94-Fer;
GN   Name=FER; Synonyms=TYK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-439.
RX   PubMed=2725517; DOI=10.1128/MCB.9.4.1587;
RA   Hao Q.-L., Heisterkamp N., Groffen J.;
RT   "Isolation and sequence analysis of a novel human tyrosine kinase
RT   gene.";
RL   Mol. Cell. Biol. 9:1587-1593(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), ALTERNATIVE PROMOTER USAGE,
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=22223638; DOI=10.1074/jbc.M111.327106;
RA   Makovski A., Yaffe E., Shpungin S., Nir U.;
RT   "Intronic promoter drives the BORIS-regulated expression of FerT in
RT   colon carcinoma cells.";
RL   J. Biol. Chem. 287:6100-6112(2012).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 686-741.
RX   PubMed=8247543;
RA   Lee S.-T., Strunk K.M., Spritz R.A.;
RT   "A survey of protein tyrosine kinase mRNAs expressed in normal human
RT   melanocytes.";
RL   Oncogene 8:3403-3410(1993).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=2156206;
RA   Krolewski J.J., Lee R., Eddy R., Shows T.B., Dalla-Favera R.;
RT   "Identification and chromosomal mapping of new human tyrosine kinase
RT   genes.";
RL   Oncogene 5:277-282(1990).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=1990274; DOI=10.1128/MCB.11.2.1180;
RA   Hao Q.-L., Ferris D.K., White G., Heisterkamp N., Groffen J.;
RT   "Nuclear and cytoplasmic location of the FER tyrosine kinase.";
RL   Mol. Cell. Biol. 11:1180-1183(1991).
RN   [9]
RP   FUNCTION IN PHOSPHORYLATION OF CTNND1, AUTOPHOSPHORYLATION, SUBUNIT,
RP   AND INTERACTION WITH CTNND1.
RX   PubMed=7623846; DOI=10.1128/MCB.15.8.4553;
RA   Kim L., Wong T.W.;
RT   "The cytoplasmic tyrosine kinase FER is associated with the catenin-
RT   like substrate pp120 and is activated by growth factors.";
RL   Mol. Cell. Biol. 15:4553-4561(1995).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF CTTN, INTERACTION WITH CTTN; CTNND1 AND
RP   PDGFR, MUTAGENESIS OF LYS-591, AND SUBCELLULAR LOCATION.
RX   PubMed=9722593; DOI=10.1074/jbc.273.36.23542;
RA   Kim L., Wong T.W.;
RT   "Growth factor-dependent phosphorylation of the actin-binding protein
RT   cortactin is mediated by the cytoplasmic tyrosine kinase FER.";
RL   J. Biol. Chem. 273:23542-23548(1998).
RN   [11]
RP   FUNCTION IN PHOSPHORYLATION OF PECAM1; PTPN11 AND GAB1, SUBCELLULAR
RP   LOCATION, CATALYTIC ACTIVITY, MUTAGENESIS OF ARG-483, AND INTERACTION
RP   WITH PECAM1.
RX   PubMed=12972546; DOI=10.1091/mbc.E03-02-0080;
RA   Kogata N., Masuda M., Kamioka Y., Yamagishi A., Endo A., Okada M.,
RA   Mochizuki N.;
RT   "Identification of Fer tyrosine kinase localized on microtubules as a
RT   platelet endothelial cell adhesion molecule-1 phosphorylating kinase
RT   in vascular endothelial cells.";
RL   Mol. Biol. Cell 14:3553-3564(2003).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF JUP AND IN REGULATION OF PROTEIN
RP   PHOSPHORYLATION.
RX   PubMed=14517306; DOI=10.1128/MCB.23.20.7391-7402.2003;
RA   Miravet S., Piedra J., Castano J., Raurell I., Franci C., Dunach M.,
RA   Garcia de Herreros A.;
RT   "Tyrosine phosphorylation of plakoglobin causes contrary effects on
RT   its association with desmosomes and adherens junction components and
RT   modulates beta-catenin-mediated transcription.";
RL   Mol. Cell. Biol. 23:7391-7402(2003).
RN   [13]
RP   SUBCELLULAR LOCATION, LIPID-BINDING, AND DOMAIN.
RX   PubMed=16418535; DOI=10.1083/jcb.200508091;
RA   Tsujita K., Suetsugu S., Sasaki N., Furutani M., Oikawa T.,
RA   Takenawa T.;
RT   "Coordination between the actin cytoskeleton and membrane deformation
RT   by a novel membrane tubulation domain of PCH proteins is involved in
RT   endocytosis.";
RL   J. Cell Biol. 172:269-279(2006).
RN   [14]
RP   IDENTIFICATION OF ISOFORM 3, AND TISSUE SPECIFICITY.
RX   PubMed=18985748; DOI=10.1002/dvdy.21789;
RA   Kierszenbaum A.L., Rivkin E., Tres L.L.;
RT   "Expression of Fer testis (FerT) tyrosine kinase transcript variants
RT   and distribution sites of FerT during the development of the acrosome-
RT   acroplaxome-manchette complex in rat spermatids.";
RL   Dev. Dyn. 237:3882-3891(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-402 AND SER-434, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [16]
RP   FUNCTION IN PHOSPHORYLATION OF PTK2/FAK1, FUNCTION IN REGULATION OF
RP   ACTIN CYTOSKELETON, SUBUNIT, AND IDENTIFICATION IN A COMPLEX WITH CTTN
RP   AND PTK2/FAK1.
RX   PubMed=19339212; DOI=10.1016/j.bbamcr.2009.01.015;
RA   Oh M.A., Choi S., Lee M.J., Choi M.C., Lee S.A., Ko W., Cance W.G.,
RA   Oh E.S., Buday L., Kim S.H., Lee J.W.;
RT   "Specific tyrosine phosphorylation of focal adhesion kinase mediated
RT   by Fer tyrosine kinase in suspended hepatocytes.";
RL   Biochim. Biophys. Acta 1793:781-791(2009).
RN   [17]
RP   INTERACTION WITH HSP90.
RX   PubMed=19159681; DOI=10.1016/j.cellsig.2008.12.011;
RA   Hikri E., Shpungin S., Nir U.;
RT   "Hsp90 and a tyrosine embedded in the Hsp90 recognition loop are
RT   required for the Fer tyrosine kinase activity.";
RL   Cell. Signal. 21:588-596(2009).
RN   [18]
RP   FUNCTION IN IL6 SIGNALING PATHWAY; CELL PROLIFERATION AND IN
RP   PHOSPHORYLATION OF STAT3, AND INTERACTION WITH STAT3.
RX   PubMed=19147545; DOI=10.1158/1541-7786.MCR-08-0117;
RA   Zoubeidi A., Rocha J., Zouanat F.Z., Hamel L., Scarlata E.,
RA   Aprikian A.G., Chevalier S.;
RT   "The Fer tyrosine kinase cooperates with interleukin-6 to activate
RT   signal transducer and activator of transcription 3 and promote human
RT   prostate cancer cell growth.";
RL   Mol. Cancer Res. 7:142-155(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-402 AND SER-434, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [20]
RP   FUNCTION IN REGULATION OF ACTIN CYTOSKELETON AND CELL MIGRATION,
RP   CATALYTIC ACTIVITY, DOMAIN, LIPID-BINDING, AND ENZYME REGULATION.
RX   PubMed=19738202; DOI=10.1126/scisignal.2000393;
RA   Itoh T., Hasegawa J., Tsujita K., Kanaho Y., Takenawa T.;
RT   "The tyrosine kinase Fer is a downstream target of the PLD-PA pathway
RT   that regulates cell migration.";
RL   Sci. Signal. 2:RA52-RA52(2009).
RN   [21]
RP   FUNCTION IN CELL PROLIFERATION, PHOSPHORYLATION, AND INTERACTION WITH
RP   FLT3.
RX   PubMed=20111072; DOI=10.1038/leu.2009.301;
RA   Voisset E., Lopez S., Chaix A., Georges C., Hanssens K., Prebet T.,
RA   Dubreuil P., De Sepulveda P.;
RT   "FES kinases are required for oncogenic FLT3 signaling.";
RL   Leukemia 24:721-728(2010).
RN   [22]
RP   FUNCTION IN ACTIVATION OF NF-KAPPA-B DOWNSTREAM OF EGFR AND CELL
RP   PROLIFERATION, INTERACTION WITH EGFR, AND PHOSPHORYLATION.
RX   PubMed=21518868; DOI=10.1073/pnas.1105369108;
RA   Guo C., Stark G.R.;
RT   "FER tyrosine kinase (FER) overexpression mediates resistance to
RT   quinacrine through EGF-dependent activation of NF-kappaB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:7968-7973(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   STRUCTURE BY NMR OF 453-557.
RG   Northeast structural genomics consortium (NESG);
RT   "Solution structure of SH2 domain of proto-oncogene tyrosine-protein
RT   kinase FER from Homo sapiens, Northeast structural genomics consortium
RT   (NESG) target HR3461D.";
RL   Submitted (AUG-2009) to the PDB data bank.
RN   [25]
RP   REVIEW.
RX   PubMed=11994747; DOI=10.1038/nrm783;
RA   Greer P.;
RT   "Closing in on the biological functions of Fps/Fes and Fer.";
RL   Nat. Rev. Mol. Cell Biol. 3:278-289(2002).
RN   [26]
RP   VARIANT VAL-439.
RX   PubMed=1651563; DOI=10.1126/science.1651563;
RA   Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A.,
RA   Koyama K., Utsunomiya J., Baba S., Hedge P., Markham A., Krush A.J.,
RA   Petersen G.M., Hamilton S.R., Nilbert M.C., Levy D.B., Bryan T.M.,
RA   Preisinger A.C., Smith K.J., Su L.-K., Kinzler K.W., Vogelstein B.;
RT   "Mutations of chromosome 5q21 genes in FAP and colorectal cancer
RT   patients.";
RL   Science 253:665-669(1991).
RN   [27]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-128; GLN-404; VAL-412; VAL-439;
RP   PRO-443; CYS-460 AND GLN-813.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Tyrosine-protein kinase that acts downstream of cell
CC       surface receptors for growth factors and plays a role in the
CC       regulation of the actin cytoskeleton, microtubule assembly,
CC       lamellipodia formation, cell adhesion, cell migration and
CC       chemotaxis. Acts downstream of EGFR, KIT, PDGFRA and PDGFRB. Acts
CC       downstream of EGFR to promote activation of NF-kappa-B and cell
CC       proliferation. May play a role in the regulation of the mitotic
CC       cell cycle. Plays a role in the insulin receptor signaling pathway
CC       and in activation of phosphatidylinositol 3-kinase. Acts
CC       downstream of the activated FCER1 receptor and plays a role in
CC       FCER1 (high affinity immunoglobulin epsilon receptor)-mediated
CC       signaling in mast cells. Plays a role in the regulation of mast
CC       cell degranulation. Plays a role in leukocyte recruitment and
CC       diapedesis in response to bacterial lipopolysaccharide (LPS).
CC       Plays a role in synapse organization, trafficking of synaptic
CC       vesicles, the generation of excitatory postsynaptic currents and
CC       neuron-neuron synaptic transmission. Plays a role in neuronal cell
CC       death after brain damage. Phosphorylates CTTN, CTNND1, PTK2/FAK1,
CC       GAB1, PECAM1 and PTPN11. May phosphorylate JUP and PTPN1. Can
CC       phosphorylate STAT3, but the biological relevance of this depends
CC       on cell type and stimulus. {ECO:0000269|PubMed:12972546,
CC       ECO:0000269|PubMed:14517306, ECO:0000269|PubMed:19147545,
CC       ECO:0000269|PubMed:19339212, ECO:0000269|PubMed:19738202,
CC       ECO:0000269|PubMed:20111072, ECO:0000269|PubMed:21518868,
CC       ECO:0000269|PubMed:22223638, ECO:0000269|PubMed:7623846,
CC       ECO:0000269|PubMed:9722593}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028, ECO:0000269|PubMed:12972546,
CC       ECO:0000269|PubMed:19738202}.
CC   -!- ENZYME REGULATION: Activated by phosphatidic acid binding.
CC       Activated by hydrogen peroxide (in vitro). Activated by reactive
CC       oxygen species (ROS). {ECO:0000269|PubMed:19738202}.
CC   -!- SUBUNIT: Homotrimer. Interacts with ARHGDIA, IRS1, JAK1, NRP1,
CC       PIK3R1, PLEC and TMF1. Interacts with PPP1CA and regulates its
CC       phosphorylation at 'Thr-320' (By similarity). Interacts with
CC       CTNND1, EGFR, FLT3, PECAM1, PDGFR and STAT3. Interacts (via SH2
CC       domain) with CTTN. Interacts with HSP90; this stabilizes
CC       phosphorylated FER and protects FER against proteasomal
CC       degradation. Component of a complex that contains at least FER,
CC       CTTN and PTK2/FAK1. {ECO:0000250, ECO:0000269|PubMed:12972546,
CC       ECO:0000269|PubMed:19147545, ECO:0000269|PubMed:19159681,
CC       ECO:0000269|PubMed:19339212, ECO:0000269|PubMed:20111072,
CC       ECO:0000269|PubMed:21518868, ECO:0000269|PubMed:7623846,
CC       ECO:0000269|PubMed:9722593}.
CC   -!- INTERACTION:
CC       O42486:Bcat (xeno); NbExp=2; IntAct=EBI-1380661, EBI-972394;
CC       Q16543:CDC37; NbExp=2; IntAct=EBI-1380661, EBI-295634;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton. Cell
CC       membrane; Peripheral membrane protein; Cytoplasmic side. Cell
CC       projection. Cell junction. Membrane; Peripheral membrane protein;
CC       Cytoplasmic side. Nucleus. Cytoplasm, cell cortex. Note=Associated
CC       with the chromatin. Detected on microtubules in polarized and
CC       motile vascular endothelial cells. Colocalizes with F-actin at the
CC       cell cortex. Colocalizes with PECAM1 and CTNND1 at nascent cell-
CC       cell contacts.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=p94;
CC         IsoId=P16591-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P16591-2; Sequence=VSP_041765;
CC       Name=3; Synonyms=FerT, p47;
CC         IsoId=P16591-3; Sequence=VSP_043846, VSP_043847;
CC         Note=Produced by alternative promoter usage.;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is detected in normal colon and in
CC       fibroblasts (at protein level). Isoform 3 is detected in normal
CC       testis, in colon carcinoma-derived metastases in lung, liver and
CC       ovary, and in colon carcinoma and hepato carcinoma cell lines (at
CC       protein level). Isoform 3 is not detected in normal colon or in
CC       normal fibroblasts (at protein level). Widely expressed.
CC       {ECO:0000269|PubMed:18985748, ECO:0000269|PubMed:2156206,
CC       ECO:0000269|PubMed:22223638}.
CC   -!- DOMAIN: The coiled coil domains mediate homooligomerization and
CC       are required for location at microtubules.
CC   -!- DOMAIN: The N-terminal region including the first coiled coil
CC       domain mediates interaction with phosphoinositide-containing
CC       membranes.
CC   -!- PTM: Autophosphorylated. {ECO:0000269|PubMed:20111072,
CC       ECO:0000269|PubMed:21518868}.
CC   -!- PTM: Polyubiquitinated; this leads to proteasomal degradation.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Fes/fps subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03358; AAA61190.1; -; mRNA.
DR   EMBL; JQ412173; AEY69041.1; -; mRNA.
DR   EMBL; AK299855; BAG61714.1; -; mRNA.
DR   EMBL; AK315234; BAG37661.1; -; mRNA.
DR   EMBL; AC034207; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008871; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC109481; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008955; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010228; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011421; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC116428; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471086; EAW49055.1; -; Genomic_DNA.
DR   CCDS; CCDS4098.1; -. [P16591-1]
DR   CCDS; CCDS78044.1; -. [P16591-3]
DR   PIR; A31943; TVHUFE.
DR   RefSeq; NP_001294957.1; NM_001308028.1. [P16591-2]
DR   RefSeq; NP_001294960.1; NM_001308031.1. [P16591-3]
DR   RefSeq; NP_001294967.1; NM_001308038.1.
DR   RefSeq; NP_005237.2; NM_005246.3. [P16591-1]
DR   RefSeq; XP_011541573.1; XM_011543271.2. [P16591-1]
DR   RefSeq; XP_016864719.1; XM_017009230.1. [P16591-1]
DR   RefSeq; XP_016864720.1; XM_017009231.1. [P16591-1]
DR   UniGene; Hs.107418; -.
DR   UniGene; Hs.221472; -.
DR   UniGene; Hs.625304; -.
DR   PDB; 2KK6; NMR; -; A=453-557.
DR   PDBsum; 2KK6; -.
DR   ProteinModelPortal; P16591; -.
DR   SMR; P16591; -.
DR   BioGrid; 108532; 21.
DR   IntAct; P16591; 18.
DR   MINT; MINT-261636; -.
DR   STRING; 9606.ENSP00000281092; -.
DR   BindingDB; P16591; -.
DR   ChEMBL; CHEMBL3982; -.
DR   GuidetoPHARMACOLOGY; 2022; -.
DR   iPTMnet; P16591; -.
DR   PhosphoSitePlus; P16591; -.
DR   BioMuta; FER; -.
DR   DMDM; 97536202; -.
DR   EPD; P16591; -.
DR   PaxDb; P16591; -.
DR   PeptideAtlas; P16591; -.
DR   PRIDE; P16591; -.
DR   DNASU; 2241; -.
DR   Ensembl; ENST00000281092; ENSP00000281092; ENSG00000151422. [P16591-1]
DR   Ensembl; ENST00000618353; ENSP00000484767; ENSG00000151422. [P16591-3]
DR   GeneID; 2241; -.
DR   KEGG; hsa:2241; -.
DR   UCSC; uc031skp.2; human. [P16591-1]
DR   CTD; 2241; -.
DR   DisGeNET; 2241; -.
DR   GeneCards; FER; -.
DR   HGNC; HGNC:3655; FER.
DR   HPA; CAB022464; -.
DR   HPA; HPA007641; -.
DR   MIM; 176942; gene.
DR   neXtProt; NX_P16591; -.
DR   OpenTargets; ENSG00000151422; -.
DR   PharmGKB; PA28095; -.
DR   eggNOG; KOG0194; Eukaryota.
DR   eggNOG; ENOG410Y6RP; LUCA.
DR   GeneTree; ENSGT00760000119011; -.
DR   HOGENOM; HOG000059550; -.
DR   HOVERGEN; HBG005655; -.
DR   InParanoid; P16591; -.
DR   KO; K08889; -.
DR   OMA; QYADNQY; -.
DR   OrthoDB; EOG091G01S4; -.
DR   PhylomeDB; P16591; -.
DR   TreeFam; TF315363; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-1433557; Signaling by SCF-KIT.
DR   SignaLink; P16591; -.
DR   SIGNOR; P16591; -.
DR   ChiTaRS; FER; human.
DR   EvolutionaryTrace; P16591; -.
DR   GeneWiki; FER_(gene); -.
DR   GenomeRNAi; 2241; -.
DR   PRO; PR:P16591; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000151422; -.
DR   CleanEx; HS_FER; -.
DR   ExpressionAtlas; P16591; baseline and differential.
DR   Genevisible; P16591; HS.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IDA:UniProtKB.
DR   GO; GO:0008289; F:lipid binding; IDA:UniProtKB.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IEA:Ensembl.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0008283; P:cell proliferation; IMP:UniProtKB.
DR   GO; GO:0044331; P:cell-cell adhesion mediated by cadherin; ISS:UniProtKB.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB.
DR   GO; GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; IMP:UniProtKB.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; ISS:UniProtKB.
DR   GO; GO:0006935; P:chemotaxis; IBA:GO_Central.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0050904; P:diapedesis; ISS:UniProtKB.
DR   GO; GO:0035426; P:extracellular matrix-cell signaling; ISS:UniProtKB.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0038028; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; ISS:UniProtKB.
DR   GO; GO:0070102; P:interleukin-6-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0038109; P:Kit signaling pathway; ISS:UniProtKB.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0033007; P:negative regulation of mast cell activation involved in immune response; ISS:UniProtKB.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IBA:GO_Central.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0048008; P:platelet-derived growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IMP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:CACAO.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0042058; P:regulation of epidermal growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0010762; P:regulation of fibroblast migration; IEA:Ensembl.
DR   GO; GO:0010591; P:regulation of lamellipodium assembly; IDA:UniProtKB.
DR   GO; GO:0043304; P:regulation of mast cell degranulation; IBA:GO_Central.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB.
DR   GO; GO:0036119; P:response to platelet-derived growth factor; ISS:UniProtKB.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; ISS:UniProtKB.
DR   GO; GO:0042503; P:tyrosine phosphorylation of Stat3 protein; IDA:UniProtKB.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR027267; AH/BAR-dom.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR028539; Fer.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR016250; Tyr-prot_kinase_Fes/Fps.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   PANTHER; PTHR24418:SF329; PTHR24418:SF329; 1.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   PIRSF; PIRSF000632; TyrPK_fps; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Alternative splicing;
KW   ATP-binding; Cell junction; Cell membrane; Cell projection;
KW   Coiled coil; Complete proteome; Cytoplasm; Cytoskeleton; Kinase;
KW   Lipid-binding; Membrane; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome; SH2 domain;
KW   Transferase; Tyrosine-protein kinase; Ubl conjugation.
FT   CHAIN         1    822       Tyrosine-protein kinase Fer.
FT                                /FTId=PRO_0000088084.
FT   DOMAIN        1    259       F-BAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01077}.
FT   DOMAIN      460    550       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      563    816       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     569    577       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION        1    300       Important for interaction with membranes
FT                                containing phosphoinositides.
FT   COILED      123    185       {ECO:0000255}.
FT   COILED      301    390       {ECO:0000255}.
FT   ACT_SITE    684    684       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     591    591       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     402    402       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES     434    434       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     615    615       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     714    714       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:P70451}.
FT   VAR_SEQ       1    369       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:22223638}.
FT                                /FTId=VSP_043846.
FT   VAR_SEQ       1    175       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041765.
FT   VAR_SEQ     370    412       LRCTEAKFSAQKELLEQKVQENDGKEPPPVVNYEEDARSVT
FT                                SM -> MEQKMKCPHCKDQLESGFGSQSCKTCALMFSSEPS
FT                                TSEVHRDQ (in isoform 3).
FT                                {ECO:0000303|PubMed:22223638}.
FT                                /FTId=VSP_043847.
FT   VARIANT     128    128       V -> F (in dbSNP:rs35150210).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041691.
FT   VARIANT     404    404       E -> Q (in an ovarian Endometrioid
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041692.
FT   VARIANT     412    412       M -> V (in dbSNP:rs33940843).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041693.
FT   VARIANT     439    439       L -> V (in dbSNP:rs34499946).
FT                                {ECO:0000269|PubMed:1651563,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:2725517}.
FT                                /FTId=VAR_006282.
FT   VARIANT     443    443       A -> P (in dbSNP:rs34259824).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041694.
FT   VARIANT     460    460       W -> C (in a lung small cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041695.
FT   VARIANT     507    507       I -> T (in dbSNP:rs34204308).
FT                                /FTId=VAR_051695.
FT   VARIANT     813    813       E -> Q (in dbSNP:rs56097357).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041696.
FT   MUTAGEN     483    483       R->Q: Abolishes kinase activity.
FT                                Abolishes location at microtubules.
FT                                {ECO:0000269|PubMed:12972546}.
FT   MUTAGEN     591    591       K->R: Abolishes kinase activity.
FT                                {ECO:0000269|PubMed:9722593}.
FT   CONFLICT    219    219       I -> L (in Ref. 3; BAG61714).
FT                                {ECO:0000305}.
FT   CONFLICT    234    234       S -> N (in Ref. 3; BAG61714).
FT                                {ECO:0000305}.
FT   CONFLICT    426    426       H -> Q (in Ref. 3; BAG61714).
FT                                {ECO:0000305}.
FT   CONFLICT    447    447       M -> L (in Ref. 2; AEY69041).
FT                                {ECO:0000305}.
FT   CONFLICT    485    485       S -> G (in Ref. 2; AEY69041).
FT                                {ECO:0000305}.
FT   CONFLICT    492    492       Y -> H (in Ref. 2; AEY69041).
FT                                {ECO:0000305}.
FT   CONFLICT    505    505       F -> L (in Ref. 3; BAG61714).
FT                                {ECO:0000305}.
FT   CONFLICT    558    558       L -> F (in Ref. 2; AEY69041).
FT                                {ECO:0000305}.
FT   CONFLICT    730    730       E -> G (in Ref. 3; BAG61714).
FT                                {ECO:0000305}.
FT   TURN        455    457       {ECO:0000244|PDB:2KK6}.
FT   STRAND      461    464       {ECO:0000244|PDB:2KK6}.
FT   HELIX       467    472       {ECO:0000244|PDB:2KK6}.
FT   STRAND      480    484       {ECO:0000244|PDB:2KK6}.
FT   STRAND      492    498       {ECO:0000244|PDB:2KK6}.
FT   STRAND      501    510       {ECO:0000244|PDB:2KK6}.
FT   STRAND      513    518       {ECO:0000244|PDB:2KK6}.
FT   STRAND      520    522       {ECO:0000244|PDB:2KK6}.
FT   HELIX       524    533       {ECO:0000244|PDB:2KK6}.
FT   TURN        540    542       {ECO:0000244|PDB:2KK6}.
SQ   SEQUENCE   822 AA;  94638 MW;  BD42DF6C03419C76 CRC64;
     MGFGSDLKNS HEAVLKLQDW ELRLLETVKK FMALRIKSDK EYASTLQNLC NQVDKESTVQ
     MNYVSNVSKS WLLMIQQTEQ LSRIMKTHAE DLNSGPLHRL TMMIKDKQQV KKSYIGVHQQ
     IEAEMIKVTK TELEKLKCSY RQLIKEMNSA KEKYKEALAK GKETEKAKER YDKATMKLHM
     LHNQYVLALK GAQLHQNQYY DITLPLLLDS LQKMQEEMIK ALKGIFDEYS QITSLVTEEI
     VNVHKEIQMS VEQIDPSTEY NNFIDVHRTT AAKEQEIEFD TSLLEENENL QANEIMWNNL
     TAESLQVMLK TLAEELMQTQ QMLLNKEEAV LELEKRIEES SETCEKKSDI VLLLSQKQAL
     EELKQSVQQL RCTEAKFSAQ KELLEQKVQE NDGKEPPPVV NYEEDARSVT SMERKERLSK
     FESIRHSIAG IIRSPKSALG SSALSDMISI SEKPLAEQDW YHGAIPRIEA QELLKKQGDF
     LVRESHGKPG EYVLSVYSDG QRRHFIIQYV DNMYRFEGTG FSNIPQLIDH HYTTKQVITK
     KSGVVLLNPI PKDKKWILSH EDVILGELLG KGNFGEVYKG TLKDKTSVAV KTCKEDLPQE
     LKIKFLQEAK ILKQYDHPNI VKLIGVCTQR QPVYIIMELV SGGDFLTFLR RKKDELKLKQ
     LVKFSLDAAA GMLYLESKNC IHRDLAARNC LVGENNVLKI SDFGMSRQED GGVYSSSGLK
     QIPIKWTAPE ALNYGRYSSE SDVWSFGILL WETFSLGVCP YPGMTNQQAR EQVERGYRMS
     APQHCPEDIS KIMMKCWDYK PENRPKFSEL QKELTIIKRK LT
//
